“The past 12 months have seen a rapid shift towards TV-like audience guarantees in digital video, aided by tools like Nielsen Online Campaign Ratings that provide independent verification of ...
We are initiating coverage of Adaptimmune Therapeutics plc (NASDAQ:ADAP) with a 12-month price target of $3.00, translating into sizeable upside from the stock’s current price. Adaptimmune designs, ...
Pre-market open on 3/20/25, Adaptimmune (NASDAQ:ADAP) provided a business update for 4Q24 (in lieu of financial results for the quarter/full year to be released in conjunction with the company’s 10-K ...
Adap.tv today announced In-Target Audience Optimization - the industry’s first technology that enables advertisers to maximize delivery against demographic audiences as measured by verification ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback